Q2 2021 Holdings
Filed 2021-08-16 | 17 holdings | $105.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cullinan Oncology, Inc.(CGEM) | COM | 230031106 | $70.3M | 2,731,410 | 66.8% |
| Aclaris Therapeutics, Inc.(ACRS) | COM | 00461U105 | $22.1M | 1,258,243 | 21.0% |
| ALX Oncology Holdings Inc.(ALXO) | COM | 00166B105 | $12.6M | 231,200 | 12.0% |
| Quantum-Si Incorporated(QSI) | COM CL A | 74765K105 | $28.7K | 2,342,061 | 0.0% |
| Kinnate Biopharma Inc. | COM | 49705R105 | $20.4K | 875,001 | 0.0% |
| Gemini Therapeutics, Inc. | COM | 36870G105 | $15.8K | 2,435,125 | 0.0% |
| Relay Therapeutics, Inc.(RLAY) | COM | 75943R102 | $14.6K | 400,000 | 0.0% |
| Nurix Therapeutics, Inc.(NRIX) | COM | 67080M103 | $12.0K | 451,522 | 0.0% |
| Hims & Hers Health, Inc.(HIMS) | COM CL A | 433000106 | $11.5K | 1,056,922 | 0.0% |
| Population Health Investment Co., Inc. | UNIT | G71716123 | $9.7K | 960,000 | 0.0% |
| 23andMe Holding Co. | COM CL A | 90138Q108 | $8.2K | 700,000 | 0.0% |
| Pharvaris N.V.(PHVS) | COM | N69605108 | $6.8K | 364,142 | 0.0% |
| FS Development Corp. II | COM CL A | 30318F100 | $6.0K | 602,500 | 0.0% |
| Research Alliance Corp. II | COM CL A | 760873109 | $5.1K | 500,000 | 0.0% |
| Bctg Acquisition Corp. | COM | 05492W103 | $4.6K | 400,000 | 0.0% |
| Lucira Health, Inc. | COM | 54948U105 | $3.2K | 485,000 | 0.0% |
| Helix Acquisition Corp. | COM CL A | G4444C102 | $2.6K | 250,000 | 0.0% |